U.S. Department of Health & Human Services
National Institutes of Health
NCATS
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
Show Filters
Hide Filters
Primary Target
histone deacetylase
1
Histamine H1 receptor
315
Dopamine D2 receptor
297
DNA
278
Bacterial penicillin-binding protein
233
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Development Status
Possibly Marketed Outside US
1
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Approval Year
2022
1
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Substance Class
Chemical
1
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Code System
CAS
1
DAILYMED
1
EPA CompTox
1
FDA UNII
1
MESH
1
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Substance Form
Principal Form
1
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Primary Target
histone deacetylase
Showing
1 - 1
of
1
results
Search within data set
First page disabled
Previous page disabled
1
Next page disabled
Next page disabled
Sort By
Approval Year, Recent
Approval Year, Oldest
Relevance
Display Name, A-Z
Display Name, Z-A
Least References
Most References
Oldest Change
Newest Change
POMIFERIN
MORE DETAILS
74YIS40APM
Export Data
Search for Structure
Status:
Possibly Marketed Outside US
First approved in 2022
Class (Stereo):
CHEMICAL (ACHIRAL)
Targets:
Carbonic anhydrase 2
5
Carbonic anhydrase 1
3
histone deacetylase
1
